---
title: "礼来公司等申请者在最高法院拒绝多项上诉时被拒绝受理申请"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286789989.md"
description: "礼来在被最高法院拒绝的制药公司中，该法院驳回了与医疗保健和商业案件相关的多项上诉。此决定降低了最高法院在这些问题上立即介入的可能性。消息公布后，礼来的股价下跌了 2.2%，至 985.25 美元"
datetime: "2026-05-18T14:29:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286789989.md)
  - [en](https://longbridge.com/en/news/286789989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286789989.md)
---

# 礼来公司等申请者在最高法院拒绝多项上诉时被拒绝受理申请

10:29 AM EDT, 05/18/2026 (MT Newswires) -- Eli Lilly ( LLY ) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders.

The Court vacated and remanded several cases, including voting rights disputes, while rejecting review in multiple pharmaceutical and healthcare-related petitions, reducing the likelihood of near-term Supreme Court intervention in those matters.

The Court granted review in one education case while denying dozens of appeals across civil, criminal, regulatory, and healthcare matters, with Justice Sotomayor separately concurring in the denial of certiorari in a sentencing case in which relief had already been granted.

Shares of Eli Lilly ( LLY ) were down 2.2% in Monday trading.

Price: 985.25, Change: -19.68, Percent Change: -1.96

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### 相关股票

- [LLY.US](https://longbridge.com/zh-CN/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/zh-CN/quote/LLYX.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [ELIS.US](https://longbridge.com/zh-CN/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/zh-CN/quote/LLYZ.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [ELIL.US](https://longbridge.com/zh-CN/quote/ELIL.US.md)
- [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [LABD.US](https://longbridge.com/zh-CN/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)

## 相关资讯与研究

- [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md)
- [礼来公司（LLY）代表了肥胖潮流。市场是否已经将这一因素计入价格中？](https://longbridge.com/zh-CN/news/286727957.md)
- [“搞钱”，才是 Revolution 千亿神话密码](https://longbridge.com/zh-CN/news/286888792.md)
- [默沙东 ADC 药物达 III 期主要终点](https://longbridge.com/zh-CN/news/286929703.md)
- [BioMarin ENPP1 缺乏症三期临床试验折戟，BMN 401 未达临床获益终点](https://longbridge.com/zh-CN/news/286795745.md)